Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience-Reference-Cited by-同舟云学术

Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience

Published:2021-09-01 Issue:12 Volume:26 Page:2275-2281
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Uchihara Masaki,Tanioka Maki^ORCID,Kojima Yuki,Nishikawa Tadaaki,Sudo Kazuki,Shimoi Tatsunori,Noguchi Emi,Maeshima Akiko Miyagi,Yonemori Kan

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-02021-8.pdf

Reference29 articles.

1. Kebebew E, Reiff E, Duh QY et al (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30:872–878. https://doi.org/10.1007/s00268-005-0329-x

2. Kerkhofs TMA, Verhoeven RHA, Van der Zwan JM et al (2013) Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur J Cancer 49:2579–2586. https://doi.org/10.1016/j.ejca.2013.02.034

3. Fassnacht M, Dekkers OM, Else T et al (2018) European journal of endocrinology European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Guillaume Assie 10:19. https://doi.org/10.1530/EJE-18-0608

4. Fassnacht M, Terzolo M, Allolio B et al (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366:2189–2197. https://doi.org/10.1056/NEJMoa1200966

5. Shuayb M, Das A, Uddin MN (2019) Long-term survival in recurrent adrenocortical cancer. BMJ Support Palliat Care 9:47–50. https://doi.org/10.1136/bmjspcare-2018-001568

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Letter RE: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study;European Journal of Cancer;2024-05

2. Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study;European Journal of Cancer;2024-01

3. Clinical Issues and Suggestions: Dashboard Visualization of the Trajectory of Patients with Malignant Hormone-Producing Tumors for Precision Medicine;2023 Workshop on Visual Analytics in Healthcare (VAHC);2023-10-22

4. Molecular genetic aspects of adrenocortical cancer;Advances in Molecular Oncology;2023-07-10

5. Adrenocortical Carcinoma;Surgical Oncology Clinics of North America;2023-04